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Mycoplasma Pneumoniae infections in the Maltese islands 
A. Portelli*, C. Barbara* * 
This article is based on a paper presented at the IVth Maltese Medical School Conference held at the 
Mediterranean Conference Centre on 10_14th March 1999. 
ABSTRACT: Mycoplasma pneumoniae is a free living micro-organism which is classified in the 
family Mycoplasmataceae. It is primarily a human respiratory pathogen and the infection may 
vary from a mild pharyngitis to a pneumonia. M. pneumoniae infections are usually endemic in 
the community but periodic epidemics can also occur. These micro-organisms are sensitive to 
specific antibiotics such as tetracycline and erythromycin and a laboratory diagnosis using rapid 
methods is therefore important. Studies were carried out at the Virology Laboratory, St. Luke's 
Hospital involving 1,022 cases during the period 1995 to 1998. These were examined for specific 
anti-mycoplasmal IgM antibodies using an enzyme immunoassay (EIA) technique. One hundred 
and forty samples or 13.7% were found to be reactive. Compared to the traditional cultural 
methods, EIA techniques are very rapid laboratory diagnostic methods, the result being commu­
nicated to the clinician within a few hours. The differential diagnosis of the particular case can 
thus be resolved quickly and appropriate antibiotic therapy instituted without much delay for 
the maximum benefit to the patient. 
'Department of Pathology, University of Malta Medical School, Gwardamangia, Malta 

"Department of Pathology, Virology Laboratory, St. Luke's Hospital, Gwardamangia, Malta 

Correspondence: Dr. Alfred Portelli, Department of Pathology, University of Malta Medical School, Gwardaman­
gia, Malta. E-mail: alfport@hotmail.com 
Keywords: Mycoplasma pneumoniae, rapid laboratory methods, specific antibiotics 
Introduction encephalitis7. 
M. pneumoniae forms pleomorphic filaments with an 
Mycoplasma pneumoniae, also called Eaton's agent average diameter of about 0.51Am and lacks the pepti­
after the investigator who discovered it, is a free-living doglycan cell wall component characterisitic of bacteria. 
micro-organism which is classified in the genus My­ The absence of the peptidoglycan makes this micro­
coplasma in the family Mycoplasmataceae '. It is a hu­ organism resistant to penicillins, cephalosporins and 
man pathogen and mainly causes respiratory diseases other antibiotics which interfere with the integrity of 
ranging from mild pharnygitis to tracheobronchitis and this structure. The cytoplasmic contents are enclosed in 
pneumonia2• The latter infection is usually insidious in a well-developed plasma membrane. The major anti­
onset with generalised malaise, pyrexia and headache. genic determinants are present in this membrane and are 
The symptoms usually increase within a couple of days composed of glycolipids and proteins. Cross-reactivity 
and a hacking non-productive cough develops. Tired­ of these antigens with human tissues and other micro­
ness and marked weakness are also common. A maculo­ organisms occurs. M. pneumoniae is fastidious and 
papular rash may appear in about 15% of cases. Muscle grows slowly on complex enriched media giving rise to 
tenderness and arthralgias are common in all age colonies which have a homogenous granular morphol­
groups. The infection is seen especially in older children ogy unlike the "fried-egg" appearance of other my-
and young adults, being milder and asympto­
Jan-Mar Apr-Jun Jul-Sep Oct-Decmatic in pre-school children3.4. M. pneumo­
niae infections are endemic in the community Reactive 38 33 19 27 
but epidemics occur every 4-5 years. Non­ Samples
respiratory manifestations caused by M. 
Non Reactive 348 243 157 163pneumoniae include mucocutaneous Samples
eruptions and haemolytic anaemias the latter 
being possibly due to the development of Total No. of 386 276 176 190 
'cold agglutinins ', pericarditis and myocardi­ samples tested 
tis6 and neurological involvement such as Table 1 - Total Mycoplasma samples according to season 
meningism, aseptic meningitis or meningo­
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unknown origin. The patients' age varied 
from infants of a few months to elderly 
people in their eighties. The test chosen 
for the laboratory diagnosis was an01995 
enzyme immunoassay test for the detec­01996 tion of anti-mycoplasma IgM antibodies 
.1997 and adapted to microtitre plate technology 
Ill] 1998 employing the reverse EIA technique 
(Savyon Diagnostics Ltd, Israel. 1994). 
Results 
-	
Jan-Mar Apr-Jun Jul-Sep Oct-Dec 
Trimesters 	 Out of 1,022 samples examined, 140 or 
13.7% were found to be reactive to M. 
pneumoniae. Table 1 and Figures depict 
Fig 1 - Reactive Mycoplasma samples according to season (n=117) the reactive samples according to season, 
age group, sex and locality. The data in 
coplasmas. The colonies are very small and details can each Figure may not necessarily add to the total number 
only be seen with a colonial microscope. Unlike other of reactive samples because the data on some cards sub­
species which are facultatively anaerobic, M. pneumo­ mitted to the laboratory with the samples was missing or 
niae grows aerobicalll. the writing was illegible. Table 1 and Figure 1 show that 
Although mycoplasmas are considered to be bacteria, out of 117 reactive samples, 38 were positive during the 
the laboratory diagnosis of this 'paraviral' is traditionally January-March period, 33 in the second period, 19 in 
carried out in a virology laboratory. Besides cultural the third and 27 during the October-December period. 
methods, the serological assays most frequently em­ Figure 2 shows 99 reactive samples according to age 
ployed are the cold agglutination and complement fixa­ groups. Twenty-five were in the 0 to 5 years age group, 
tion tests and enzyme immunoassays. 41 in the 6 to 20 years age group while 33 were present 
in the group 21 years and over. Table 2 and Figure 3 
Materials and Methods show the number of reactive samples according to sex. 
Fifty-six out of 114 samples were from males while 58 
Studies were carried out at the Virology laboratory, St. were from females. Figure 4 shows locality distribution 
Luke's Hospital. All requests for the detection of My­ with three zones, North, Central and South, dividing the 
coplasma IgM antibodies during the four-year period Maltese population into approximately three equal 
1995 to 1998 were entered into a database. Three per­ population zones. Twenty-six samples came from pa­
cent of the samples had to be excluded because they tients living in the North part of the islands including 
lacked essential data or the samples were haemolysed. Gozo. Thirty-four samples came from the Central region 
Repeats were also excluded. One thousand and twenty­ while 33 reactive samples originated from the South. 
two samples were included and of these 52% were from As in similar studies9 local M. pneumoniae infections 
male and the rest from female patients. Ninety-four per­ were found to occur throughout the year with no consis­
cent of all referrals were from general hospitals (St. tent increased seasonal variation, although in our study, 
Luke's and Gozo General Hospital), 4% were from out­ there was a slight increase in the number of reactive 
patients ' clinics and only 2% were referred from the cases in the winter of 1997 (Fig. 1). Disease was more 
community (health centres and general practice). The common in the younger age group (Fig. 2) and there 
majority of samples were obtained from patients suffer­ were no overall differences between the sexes (Fig. 3) 
ing from respiratory disease or from cases of pyrexia of or between the different localities of the Maltese Is­
lands (Fig. 4). 
Discussion 
Age Groups 
Culture for M. pneumoniae can be carried OOto 5 
out for the laboratory diagnosis of M. 
D6 to 20 pneumoniae infection but growth is slow 

.21+ and the result can only be expected in 

about 2 to 6 weeks lO • The cold agglutina­

tion test is carried out by reacting the pa­

Z tient's serum with human group 0 erythro­

1995 1996 1997 1998 cytes incubated at 4 0c. It appears that M. 

pneumoniae possesses a surface antigen
Years 
which is similar to the I antigen of these 
red blood cell types. A positive cold agglu­
Fig 2 - Reactive Mycoplasma samples according to age group (n=99) tination assay is observed, on average, in 
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samples tested 
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4. 
only 50% of patients with M. pneumoniae infection. The 
test is not specific for M. pneumonaie and cross­
5.
reactions occur with other infective agents e.g. Epstein­
Barr virus and Adenovirusll . 
The complement fixation test utilises a lipid extract of 6. 
the pathogen but this has been shown to cross-react with 
components of human tissue as well as bacterial glycol­
ipids. It requires complicated reagent titrations which 7. 
makes this test somewhat difficult to perform even by 
experiencep laboratory workers. The test is usually sig­
8. 
1995 1996 1997 1998 
188 365 224 132 
22 37 28 27 
210 402 252 159 
105 210 114 81 
95 192 138 78 
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